Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-25 4:05 pm Unchanged | 2026-03-23 | 13D | THERAVANCE BIOPHARMA INC TBPH | Weiss Asset Management LP | 7,457,060 14.500% | 0 (Unchanged) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | THERAVANCE BIOPHARMA INC TBPH | Newtyn Management LLC | 4,300,000 8.500% | -457,403 (-9.61%) | Filing History |
| 2025-04-30 1:14 pm Sale | 2025-03-31 | 13G | THERAVANCE BIOPHARMA INC TBPH | BlackRock Inc. BLK | 3,235,696 6.500% | -492,686 (-13.21%) | Filing History |
| 2025-02-14 4:05 pm Purchase | 2024-12-31 | 13G | THERAVANCE BIOPHARMA INC TBPH | Newtyn Management LLC | 4,757,403 9.700% | 657,403 (+16.03%) | Filing History |
| 2024-11-14 09:53 am Purchase | 2024-09-30 | 13G | THERAVANCE BIOPHARMA INC TBPH | Madison Avenue International LP | 9,511,150 19.400% | 999,800 (+11.75%) | Filing History |
| 2024-11-12 5:53 pm Unchanged | 2024-09-30 | 13G | THERAVANCE BIOPHARMA INC TBPH | VANGUARD GROUP INC | 2,051,689 4.190% | 0 (Unchanged) | Filing History |
| 2024-11-04 3:33 pm Unchanged | 2024-09-30 | 13G | THERAVANCE BIOPHARMA INC TBPH | VANGUARD GROUP INC | 2,051,689 4.190% | 0 (Unchanged) | Filing History |
| 2024-11-04 2:10 pm Sale | 2024-09-30 | 13G | THERAVANCE BIOPHARMA INC TBPH | VANGUARD GROUP INC | 2,051,689 4.190% | -1,437,573 (-41.20%) | Filing History |
| 2024-10-24 4:44 pm Sale | 2024-09-30 | 13G | THERAVANCE BIOPHARMA INC TBPH | BlackRock Inc. BLK | 3,728,382 7.600% | -856,214 (-18.68%) | Filing |
| 2024-09-09 5:42 pm Sale | 2024-08-31 | 13G | THERAVANCE BIOPHARMA INC TBPH | BAUPOST GROUP LLC | 0 0.000% | -2,977,304 (Position Closed) | Filing History |
| 2024-08-16 4:05 pm Purchase | 2024-08-07 | 13G | THERAVANCE BIOPHARMA INC TBPH | Newtyn Management LLC | 4,100,000 8.400% | 4,100,000 (New Position) | Filing History |
| 2024-08-09 4:14 pm Sale | 2024-07-31 | 13G | THERAVANCE BIOPHARMA INC TBPH | BAUPOST GROUP LLC | 2,977,304 6.120% | -4,441,922 (-59.87%) | Filing History |
| 2024-06-11 4:17 pm Sale | 2024-05-10 | 13G | THERAVANCE BIOPHARMA INC TBPH | ODRE 2005 SLU | 0 0.000% | -4,108,318 (Position Closed) | Filing History |
| 2024-05-03 5:49 pm Purchase | 2024-05-01 | 13G | THERAVANCE BIOPHARMA INC TBPH | Madison Avenue International LP | 8,511,350 17.500% | 1,499,124 (+21.38%) | Filing History |
| 2024-03-05 09:01 am Unchanged | 2024-03-01 | 13D | THERAVANCE BIOPHARMA INC TBPH | Weiss Asset Management LP | 7,457,060 15.500% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | THERAVANCE BIOPHARMA INC TBPH | Irenic Capital Management LP | 2,760,948 5.500% | 2,760,948 (New Position) | Filing History |
| 2024-02-13 5:15 pm Sale | 2023-12-29 | 13G | THERAVANCE BIOPHARMA INC TBPH | VANGUARD GROUP INC | 3,489,262 7.010% | -2,069,577 (-37.23%) | Filing History |
| 2024-02-08 4:54 pm Sale | 2023-12-31 | 13G | THERAVANCE BIOPHARMA INC TBPH | BlackRock Inc. BLK | 4,584,596 9.200% | -745,234 (-13.98%) | Filing |
| 2023-08-14 5:05 pm Unchanged | 2023-08-09 | 13D | THERAVANCE BIOPHARMA INC TBPH | Weiss Asset Management LP | 7,457,060 14.120% | 0 (Unchanged) | Filing History |
| 2023-07-10 4:33 pm Sale | 2023-06-30 | 13G | THERAVANCE BIOPHARMA INC TBPH | BAUPOST GROUP LLC | 7,419,226 12.840% | -4,000,000 (-35.03%) | Filing History |